Experimental investigation of herpes simplex virus latency - PubMed (original) (raw)
Review
Experimental investigation of herpes simplex virus latency
E K Wagner et al. Clin Microbiol Rev. 1997 Jul.
Abstract
The clinical manifestations of herpes simplex virus infection generally involve a mild and localized primary infection followed by asymptomatic (latent) infection interrupted sporadically by periods of recrudescence (reactivation) where virus replication and associated cytopathologic findings are manifest at the site of initial infection. During the latent phase of infection, viral genomes, but not infectious virus itself, can be detected in sensory and autonomic neurons. The process of latent infection and reactivation has been subject to continuing investigation in animal models and, more recently, in cultured cells. The initiation and maintenance of latent infection in neurons are apparently passive phenomena in that no virus gene products need be expressed or are required. Despite this, a single latency-associated transcript (LAT) encoded by DNA encompassing about 6% of the viral genome is expressed during latent infection in a minority of neurons containing viral DNA. This transcript is spliced, and the intron derived from this splicing is stably maintained in the nucleus of neurons expressing it. Reactivation, which can be induced by stress and assayed in several animal models, is facilitated by the expression of LAT. Although the mechanism of action of LAT-mediated facilitation of reactivation is not clear, all available evidence argues against its involving the expression of a protein. Rather, the most consistent models of action involve LAT expression playing a cis-acting role in a very early stage of the reactivation process.
Similar articles
- A comparison of herpes simplex virus type 1 and varicella-zoster virus latency and reactivation.
Kennedy PG, Rovnak J, Badani H, Cohrs RJ. Kennedy PG, et al. J Gen Virol. 2015 Jul;96(Pt 7):1581-602. doi: 10.1099/vir.0.000128. Epub 2015 Mar 20. J Gen Virol. 2015. PMID: 25794504 Free PMC article. Review. - Herpes Simplex Virus 2 Latency-Associated Transcript (LAT) Region Mutations Do Not Identify a Role for LAT-Associated MicroRNAs in Viral Reactivation in Guinea Pig Genital Models.
Kawamura Y, Bosch-Marce M, Tang S, Patel A, Krause PR. Kawamura Y, et al. J Virol. 2018 Jun 29;92(14):e00642-18. doi: 10.1128/JVI.00642-18. Print 2018 Jul 15. J Virol. 2018. PMID: 29720520 Free PMC article. - Increased neurovirulence and reactivation of the herpes simplex virus type 1 latency-associated transcript (LAT)-negative mutant dLAT2903 with a disrupted LAT miR-H2.
Jiang X, Brown D, Osorio N, Hsiang C, BenMohamed L, Wechsler SL. Jiang X, et al. J Neurovirol. 2016 Feb;22(1):38-49. doi: 10.1007/s13365-015-0362-y. Epub 2015 Jun 12. J Neurovirol. 2016. PMID: 26069184 Free PMC article. - In Vivo Knockdown of the Herpes Simplex Virus 1 Latency-Associated Transcript Reduces Reactivation from Latency.
Watson ZL, Washington SD, Phelan DM, Lewin AS, Tuli SS, Schultz GS, Neumann DM, Bloom DC. Watson ZL, et al. J Virol. 2018 Jul 31;92(16):e00812-18. doi: 10.1128/JVI.00812-18. Print 2018 Aug 15. J Virol. 2018. PMID: 29875240 Free PMC article. - Viral, neuronal and immune factors which may influence herpes simplex virus (HSV) latency and reactivation.
Fraser NW, Valyi-Nagy T. Fraser NW, et al. Microb Pathog. 1993 Aug;15(2):83-91. doi: 10.1006/mpat.1993.1059. Microb Pathog. 1993. PMID: 8255209 Review. No abstract available.
Cited by
- The potential link between PML NBs and ICP0 in regulating lytic and latent infection of HSV-1.
Wang S, Long J, Zheng CF. Wang S, et al. Protein Cell. 2012 May;3(5):372-82. doi: 10.1007/s13238-012-2021-x. Epub 2012 Apr 28. Protein Cell. 2012. PMID: 22544561 Free PMC article. Review. - Lund Human Mesencephalic (LUHMES) Neuronal Cell Line Supports Herpes Simplex Virus 1 Latency In Vitro.
Edwards TG, Bloom DC. Edwards TG, et al. J Virol. 2019 Mar 5;93(6):e02210-18. doi: 10.1128/JVI.02210-18. Print 2019 Mar 15. J Virol. 2019. PMID: 30602607 Free PMC article. - Nature and duration of growth factor signaling through receptor tyrosine kinases regulates HSV-1 latency in neurons.
Camarena V, Kobayashi M, Kim JY, Roehm P, Perez R, Gardner J, Wilson AC, Mohr I, Chao MV. Camarena V, et al. Cell Host Microbe. 2010 Oct 21;8(4):320-30. doi: 10.1016/j.chom.2010.09.007. Cell Host Microbe. 2010. PMID: 20951966 Free PMC article. - Effect of famciclovir on herpes simplex virus type 1 corneal disease and establishment of latency in rabbits.
Loutsch JM, Sainz B Jr, Marquart ME, Zheng X, Kesavan P, Higaki S, Hill JM, Tal-Singer R. Loutsch JM, et al. Antimicrob Agents Chemother. 2001 Jul;45(7):2044-53. doi: 10.1128/AAC.45.7.2044-2053.2001. Antimicrob Agents Chemother. 2001. PMID: 11408221 Free PMC article. - Specific histone tail modification and not DNA methylation is a determinant of herpes simplex virus type 1 latent gene expression.
Kubat NJ, Tran RK, McAnany P, Bloom DC. Kubat NJ, et al. J Virol. 2004 Feb;78(3):1139-49. doi: 10.1128/jvi.78.3.1139-1149.2004. J Virol. 2004. PMID: 14722269 Free PMC article.
References
- J Immunol. 1988 May 15;140(10):3610-6 - PubMed
- J Natl Cancer Inst. 1988 Jun 1;80(7):476-83 - PubMed
- J Infect Dis. 1988 Jul;158(1):117-23 - PubMed
- J Virol. 1988 Sep;62(9):3281-7 - PubMed
- J Virol. 1990 Oct;64(10):4755-60 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials